Tower Research Capital (TRC)’s Concorde International Group CIGL Stock Holding History

Tower Research Capital (TRC)’s Portfolio CIGL Stock Details CIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-39	Closed	-$63	–	5710
2025 Q4	$63	Buy	+39	New	+$90	﹤0.01%	5069

Other funds holding CIGL

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Tower Research Capital (TRC)'s CIGL Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Concorde International Group (CIGL) in Q1 2026, closing a stake of 39 shares — an estimated $63 sold.

Tower Research Capital (TRC) first reported a position in CIGL in Q4 2025 and held it in 1 quarter. The position peaked at $63 in Q4 2025. 8 funds tracked by Wall St. Rank hold CIGL as of Q1 2026.

Tower Research Capital (TRC) reported no remaining Concorde International Group position as of Q1 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 39 Concorde International Group shares in Q1 2026, an estimated $63.
Tower Research Capital (TRC) first reported a position in Concorde International Group in Q4 2025 and held it in 1 quarter.
Tower Research Capital (TRC)'s Concorde International Group position peaked at $63 in Q4 2025.
8 funds tracked by Wall St. Rank held Concorde International Group as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.